The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

被引：0
|
作者：
Rikke Mette Agesen
Amra Ciric Alibegovic
Henrik Ullits Andersen
Henning Beck-Nielsen
Peter Gustenhoff
Troels Krarup Hansen
Christoffer Hedetoft
Tonny Jensen
Claus Bogh Juhl
Susanne Søgaard Lerche
Kirsten Nørgaard
Hans-Henrik Parving
Lise Tarnow
Birger Thorsteinsson
Ulrik Pedersen-Bjergaard
机构：
[1] Nordsjællands Hospital,Department of Endocrinology and Nephrology
[2] Steno Diabetes Center Copenhagen,Department of Endocrinology M
[3] Odense University Hospital,Faculty of Health Sciences
[4] University of Southern Denmark,Department of Endocrinology
[5] Aalborg University Hospital,Department of Medical Endocrinology
[6] Steno Diabetes Center Aarhus,Department of Diabetes and Hormonal Diseases
[7] Health,Department of Endocrinology
[8] University of Aarhus,Department of Clinical Research
[9] Department of Internal Medicine,Faculty of Health and Medical Sciences
[10] Copenhagen University Hospital (Rigshospitalet),undefined
[11] Department of Medicine,undefined
[12] Sydvestjysk Sygehus,undefined
[13] Lillebælt Hospital Kolding,undefined
[14] Hvidovre University Hospital,undefined
[15] Nordsjællands Hospital,undefined
[16] Steno Diabetes Center Sjaelland,undefined
[17] University of Copenhagen,undefined
来源：
BMC Endocrine Disorders | / 19卷
关键词：
Type 1 diabetes; Nocturnal hypoglycaemia; Severe hypoglycaemia; Insulin degludec; Insulin glargine; RCT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 34 条
  • [1] The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
    Agesen, Rikke Mette
    Alibegovic, Amra Ciric
    Andersen, Henrik Ullits
    Beck-Nielsen, Henning
    Gustenhoff, Peter
    Hansen, Troels Krarup
    Hedetoft, Christoffer
    Jensen, Tonny
    Juhl, Claus Bogh
    Lerche, Susanne Sogaard
    Norgaard, Kirsten
    Parving, Hans-Henrik
    Tarnow, Lise
    Thorsteinsson, Birger
    Pedersen-Bjergaard, Ulrik
    BMC ENDOCRINE DISORDERS, 2019, 19 (1)
  • [2] A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
    Peter Lommer Kristensen
    Ulrik Pedersen-Bjergaard
    Henning Beck-Nielsen
    Kirsten Nørgaard
    Hans Perrild
    Jens Sandahl Christiansen
    Tonny Jensen
    Hans-Henrik Parving
    Birger Thorsteinsson
    Lise Tarnow
    BMC Endocrine Disorders, 12
  • [3] A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
    Kristensen, Peter Lommer
    Pedersen-Bjergaard, Ulrik
    Beck-Nielsen, Henning
    Norgaard, Kirsten
    Perrild, Hans
    Christiansen, Jens Sandahl
    Jensen, Tonny
    Parving, Hans-Henrik
    Thorsteinsson, Birger
    Tarnow, Lise
    BMC ENDOCRINE DISORDERS, 2012, 12
  • [4] Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
    Ratner, R. E.
    Gough, S. C. L.
    Mathieu, C.
    Del Prato, S.
    Bode, B.
    Mersebach, H.
    Endahl, L.
    Zinman, B.
    DIABETES OBESITY & METABOLISM, 2013, 15 (02) : 175 - 184
  • [5] Development and Validation of a Nocturnal Hypoglycaemia Risk Model for Patients With Type 2 Diabetes Mellitus
    Gong, Chen
    Cai, Tingting
    Wang, Ying
    Xiong, Xuelian
    Zhou, Yunfeng
    Zhou, Tingting
    Sun, Qi
    Huang, Huiqun
    NURSING OPEN, 2024, 11 (10):
  • [6] Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial
    Agesen, R. M.
    Kristensen, P. L.
    Beck-Nielsen, H.
    Norgaard, K.
    Perrild, H.
    Christiansen, J. S.
    Jensen, T.
    Hougaard, P.
    Parving, H. H.
    Thorsteinsson, B.
    Tarnow, L.
    Pedersen-Bjergaard, U.
    DIABETES & METABOLISM, 2016, 42 (04) : 249 - 255
  • [7] New risk and protective factors for severe hypoglycaemia in people with type 1 diabetes
    Wohland, T.
    Holstein, J. D.
    Patzer, O. M.
    Mende, M.
    Tiemann, T.
    Koch-Tessarek, C.
    Kovacs, P.
    Holstein, A.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (05) : 407 - 414
  • [8] Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
    Athena Philis-Tsimikas
    David C. Klonoff
    Kamlesh Khunti
    Harpreet S. Bajaj
    Lawrence A. Leiter
    Melissa V. Hansen
    Lone N. Troelsen
    Steen Ladelund
    Simon Heller
    Thomas R. Pieber
    Diabetologia, 2020, 63 : 698 - 710
  • [9] Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
    Philis-Tsimikas, Athena
    Klonoff, David C.
    Khunti, Kamlesh
    Bajaj, Harpreet S.
    Leiter, Lawrence A.
    Hansen, Melissa, V
    Troelsen, Lone N.
    Ladelund, Steen
    Heller, Simon
    Pieber, Thomas R.
    DIABETOLOGIA, 2020, 63 (04) : 698 - 710
  • [10] Risk of major cardiovascular events, severe hypoglycaemia, and all-cause mortality for users of insulin degludec versus insulin glargine U100-A Danish cohort study
    Jensen, Morten Hasselstrom
    Hejlesen, Ole
    Vestergaard, Peter
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (01)
1234